Patient-Derived 3D Tumoroid Profiling

An advanced research-use service for translational studies using patient-derived tumoroids, organoid-like models, or scarce human tumor material.

NAMina Bio helps design patient-derived 3D profiling workflows that preserve biological relevance while enabling structured drug testing, imaging, and optional molecular analysis.

This service may include:

• Feasibility review of patient-derived tumor material• 3D model-development strategy for limited or precious samples• Treatment-response profiling in assay-compatible 3D formats• Optional comparison with standard-of-care agents or investigational compounds• Viability, imaging, and phenotypic assessment• Optional omics or biomarker-oriented analysis through qualified partners• Translational interpretation report

Best for: research teams developing precision-oncology, resistance-profiling, or patient-derived model programs.

Important: acceptance depends on tissue availability, viability, sample transfer conditions, ethical approvals, and project scope.

Research use only. Not for diagnostic use or treatment selection.